カテゴリー： 世界, 医療/バイオ, LP Information

世界の牛疫ウイルスワクチン市場予測 2023年-2029年

【英語タイトル】Global Rinderpest Virus Vaccine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07463）・商品コード：LP23DC07463
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の牛疫ウイルスワクチン市場」は、過去の販売実績から2022年の世界の牛疫ウイルスワクチンの総販売量を検討し、2023年から2029年の予測される牛疫ウイルスワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の牛疫ウイルスワクチンの市場規模を掲載し、XXX百万米ドル規模の世界の牛疫ウイルスワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界の牛疫ウイルスワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の牛疫ウイルスワクチン市場における各社の独自のポジションをより深く理解するために、牛疫ウイルスワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の牛疫ウイルスワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。牛疫ウイルスワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。牛疫ウイルスワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。牛疫ウイルスワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

牛疫ウイルスワクチンの世界主要メーカーとしては、Zoetis、 Merck Animal Health、 Hipra、 Boehringer-Ingelheim、 Ceva、 Creative Biolabs、 China Animal Husbandry Industry、 Jinyu Bio-technology、 TECON、 Shenzhen Huaweite Biotechnology、 Beijing Centrebio Biology、 Guangdong Winsun Bio Pharmaceutical、 SPAH、 Wuhan Keqian Biologyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の牛疫ウイルスワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では牛疫ウイルスワクチン市場をセグメンテーションし、種類別 (生ワクチン、不活化ワクチン)、用途別 (子牛、成牛)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：生ワクチン、不活化ワクチン

・用途別区分：子牛、成牛

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の牛疫ウイルスワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見た牛疫ウイルスワクチン市場成長の要因は何か？
・牛疫ウイルスワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・牛疫ウイルスワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：牛疫ウイルスワクチンの年間販売量2018-2029、地域別現状・将来分析
・牛疫ウイルスワクチンの種類別セグメント：生ワクチン、不活化ワクチン
・牛疫ウイルスワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・牛疫ウイルスワクチンの用途別セグメント：子牛、成牛
・牛疫ウイルスワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の牛疫ウイルスワクチン市場
・企業別のグローバル牛疫ウイルスワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の牛疫ウイルスワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別の牛疫ウイルスワクチン販売価格
・主要企業の牛疫ウイルスワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

牛疫ウイルスワクチンの地域別レビュー
・地域別の牛疫ウイルスワクチン市場規模2018-2023：年間販売量、売上
・主要国別の牛疫ウイルスワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカの牛疫ウイルスワクチン販売の成長
・アジア太平洋の牛疫ウイルスワクチン販売の成長
・ヨーロッパの牛疫ウイルスワクチン販売の成長
・中東・アフリカの牛疫ウイルスワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別の牛疫ウイルスワクチン販売量、売上（2018-2023）
・南北アメリカの牛疫ウイルスワクチンの種類別販売量
・南北アメリカの牛疫ウイルスワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の牛疫ウイルスワクチン販売量、売上（2018-2023）
・アジア太平洋の牛疫ウイルスワクチンの種類別販売量
・アジア太平洋の牛疫ウイルスワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の牛疫ウイルスワクチン販売量、売上（2018-2023）
・ヨーロッパの牛疫ウイルスワクチンの種類別販売量
・ヨーロッパの牛疫ウイルスワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の牛疫ウイルスワクチン販売量、売上（2018-2023）
・中東・アフリカの牛疫ウイルスワクチンの種類別販売量
・中東・アフリカの牛疫ウイルスワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・牛疫ウイルスワクチンの製造コスト構造分析
・牛疫ウイルスワクチンの製造プロセス分析
・牛疫ウイルスワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・牛疫ウイルスワクチンの主要なグローバル販売業者
・牛疫ウイルスワクチンの主要なグローバル顧客

地域別の牛疫ウイルスワクチン市場予測レビュー
・地域別の牛疫ウイルスワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・牛疫ウイルスワクチンの種類別市場規模予測
・牛疫ウイルスワクチンの用途別市場規模予測

主要企業分析
Zoetis、 Merck Animal Health、 Hipra、 Boehringer-Ingelheim、 Ceva、 Creative Biolabs、 China Animal Husbandry Industry、 Jinyu Bio-technology、 TECON、 Shenzhen Huaweite Biotechnology、 Beijing Centrebio Biology、 Guangdong Winsun Bio Pharmaceutical、 SPAH、 Wuhan Keqian Biology
・企業情報
・牛疫ウイルスワクチン製品
・牛疫ウイルスワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Rinderpest Virus Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rinderpest Virus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rinderpest Virus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rinderpest Virus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rinderpest Virus Vaccine players cover Zoetis, Merck Animal Health, Hipra, Boehringer-Ingelheim, Ceva, Creative Biolabs, China Animal Husbandry Industry, Jinyu Bio-technology and TECON, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
The anti-rinderpest virus antibody produced after immunization with rinderpest virus vaccine can resist the attack of Peste des petits ruminants virus, and has a good immune protection effect. Injection of rinderpest virus vaccine is an important measure to control the outbreak and prevalence of the disease in beef cattle farms.
LPI (LP Information)’ newest research report, the “Rinderpest Virus Vaccine Industry Forecast” looks at past sales and reviews total world Rinderpest Virus Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Rinderpest Virus Vaccine sales for 2023 through 2029. With Rinderpest Virus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rinderpest Virus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Rinderpest Virus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rinderpest Virus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rinderpest Virus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rinderpest Virus Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rinderpest Virus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Rinderpest Virus Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Live Vaccine
Inactivated Vaccine
Segmentation by application
Calf
Adult Cow
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Zoetis
Merck Animal Health
Hipra
Boehringer-Ingelheim
Ceva
Creative Biolabs
China Animal Husbandry Industry
Jinyu Bio-technology
TECON
Shenzhen Huaweite Biotechnology
Beijing Centrebio Biology
Guangdong Winsun Bio Pharmaceutical
SPAH
Wuhan Keqian Biology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rinderpest Virus Vaccine market?
What factors are driving Rinderpest Virus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rinderpest Virus Vaccine market opportunities vary by end market size?
How does Rinderpest Virus Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rinderpest Virus Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rinderpest Virus Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rinderpest Virus Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Rinderpest Virus Vaccine Segment by Type
2.2.1 Live Vaccine
2.2.2 Inactivated Vaccine
2.3 Rinderpest Virus Vaccine Sales by Type
2.3.1 Global Rinderpest Virus Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Rinderpest Virus Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rinderpest Virus Vaccine Sale Price by Type (2018-2023)
2.4 Rinderpest Virus Vaccine Segment by Application
2.4.1 Calf
2.4.2 Adult Cow
2.5 Rinderpest Virus Vaccine Sales by Application
2.5.1 Global Rinderpest Virus Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Rinderpest Virus Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rinderpest Virus Vaccine Sale Price by Application (2018-2023)
3 Global Rinderpest Virus Vaccine by Company
3.1 Global Rinderpest Virus Vaccine Breakdown Data by Company
3.1.1 Global Rinderpest Virus Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Rinderpest Virus Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Rinderpest Virus Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Rinderpest Virus Vaccine Revenue by Company (2018-2023)
3.2.2 Global Rinderpest Virus Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Rinderpest Virus Vaccine Sale Price by Company
3.4 Key Manufacturers Rinderpest Virus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rinderpest Virus Vaccine Product Location Distribution
3.4.2 Players Rinderpest Virus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rinderpest Virus Vaccine by Geographic Region
4.1 World Historic Rinderpest Virus Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Rinderpest Virus Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rinderpest Virus Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rinderpest Virus Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Rinderpest Virus Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rinderpest Virus Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rinderpest Virus Vaccine Sales Growth
4.4 APAC Rinderpest Virus Vaccine Sales Growth
4.5 Europe Rinderpest Virus Vaccine Sales Growth
4.6 Middle East & Africa Rinderpest Virus Vaccine Sales Growth
5 Americas
5.1 Americas Rinderpest Virus Vaccine Sales by Country
5.1.1 Americas Rinderpest Virus Vaccine Sales by Country (2018-2023)
5.1.2 Americas Rinderpest Virus Vaccine Revenue by Country (2018-2023)
5.2 Americas Rinderpest Virus Vaccine Sales by Type
5.3 Americas Rinderpest Virus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rinderpest Virus Vaccine Sales by Region
6.1.1 APAC Rinderpest Virus Vaccine Sales by Region (2018-2023)
6.1.2 APAC Rinderpest Virus Vaccine Revenue by Region (2018-2023)
6.2 APAC Rinderpest Virus Vaccine Sales by Type
6.3 APAC Rinderpest Virus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rinderpest Virus Vaccine by Country
7.1.1 Europe Rinderpest Virus Vaccine Sales by Country (2018-2023)
7.1.2 Europe Rinderpest Virus Vaccine Revenue by Country (2018-2023)
7.2 Europe Rinderpest Virus Vaccine Sales by Type
7.3 Europe Rinderpest Virus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rinderpest Virus Vaccine by Country
8.1.1 Middle East & Africa Rinderpest Virus Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rinderpest Virus Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Rinderpest Virus Vaccine Sales by Type
8.3 Middle East & Africa Rinderpest Virus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rinderpest Virus Vaccine
10.3 Manufacturing Process Analysis of Rinderpest Virus Vaccine
10.4 Industry Chain Structure of Rinderpest Virus Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rinderpest Virus Vaccine Distributors
11.3 Rinderpest Virus Vaccine Customer
12 World Forecast Review for Rinderpest Virus Vaccine by Geographic Region
12.1 Global Rinderpest Virus Vaccine Market Size Forecast by Region
12.1.1 Global Rinderpest Virus Vaccine Forecast by Region (2024-2029)
12.1.2 Global Rinderpest Virus Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rinderpest Virus Vaccine Forecast by Type
12.7 Global Rinderpest Virus Vaccine Forecast by Application
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Rinderpest Virus Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Rinderpest Virus Vaccine Product Portfolios and Specifications
13.2.3 Merck Animal Health Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Hipra
13.3.1 Hipra Company Information
13.3.2 Hipra Rinderpest Virus Vaccine Product Portfolios and Specifications
13.3.3 Hipra Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hipra Main Business Overview
13.3.5 Hipra Latest Developments
13.4 Boehringer-Ingelheim
13.4.1 Boehringer-Ingelheim Company Information
13.4.2 Boehringer-Ingelheim Rinderpest Virus Vaccine Product Portfolios and Specifications
13.4.3 Boehringer-Ingelheim Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boehringer-Ingelheim Main Business Overview
13.4.5 Boehringer-Ingelheim Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva Rinderpest Virus Vaccine Product Portfolios and Specifications
13.5.3 Ceva Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 Creative Biolabs
13.6.1 Creative Biolabs Company Information
13.6.2 Creative Biolabs Rinderpest Virus Vaccine Product Portfolios and Specifications
13.6.3 Creative Biolabs Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Creative Biolabs Main Business Overview
13.6.5 Creative Biolabs Latest Developments
13.7 China Animal Husbandry Industry
13.7.1 China Animal Husbandry Industry Company Information
13.7.2 China Animal Husbandry Industry Rinderpest Virus Vaccine Product Portfolios and Specifications
13.7.3 China Animal Husbandry Industry Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 China Animal Husbandry Industry Main Business Overview
13.7.5 China Animal Husbandry Industry Latest Developments
13.8 Jinyu Bio-technology
13.8.1 Jinyu Bio-technology Company Information
13.8.2 Jinyu Bio-technology Rinderpest Virus Vaccine Product Portfolios and Specifications
13.8.3 Jinyu Bio-technology Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jinyu Bio-technology Main Business Overview
13.8.5 Jinyu Bio-technology Latest Developments
13.9 TECON
13.9.1 TECON Company Information
13.9.2 TECON Rinderpest Virus Vaccine Product Portfolios and Specifications
13.9.3 TECON Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 TECON Main Business Overview
13.9.5 TECON Latest Developments
13.10 Shenzhen Huaweite Biotechnology
13.10.1 Shenzhen Huaweite Biotechnology Company Information
13.10.2 Shenzhen Huaweite Biotechnology Rinderpest Virus Vaccine Product Portfolios and Specifications
13.10.3 Shenzhen Huaweite Biotechnology Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shenzhen Huaweite Biotechnology Main Business Overview
13.10.5 Shenzhen Huaweite Biotechnology Latest Developments
13.11 Beijing Centrebio Biology
13.11.1 Beijing Centrebio Biology Company Information
13.11.2 Beijing Centrebio Biology Rinderpest Virus Vaccine Product Portfolios and Specifications
13.11.3 Beijing Centrebio Biology Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Beijing Centrebio Biology Main Business Overview
13.11.5 Beijing Centrebio Biology Latest Developments
13.12 Guangdong Winsun Bio Pharmaceutical
13.12.1 Guangdong Winsun Bio Pharmaceutical Company Information
13.12.2 Guangdong Winsun Bio Pharmaceutical Rinderpest Virus Vaccine Product Portfolios and Specifications
13.12.3 Guangdong Winsun Bio Pharmaceutical Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Guangdong Winsun Bio Pharmaceutical Main Business Overview
13.12.5 Guangdong Winsun Bio Pharmaceutical Latest Developments
13.13 SPAH
13.13.1 SPAH Company Information
13.13.2 SPAH Rinderpest Virus Vaccine Product Portfolios and Specifications
13.13.3 SPAH Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 SPAH Main Business Overview
13.13.5 SPAH Latest Developments
13.14 Wuhan Keqian Biology
13.14.1 Wuhan Keqian Biology Company Information
13.14.2 Wuhan Keqian Biology Rinderpest Virus Vaccine Product Portfolios and Specifications
13.14.3 Wuhan Keqian Biology Rinderpest Virus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Wuhan Keqian Biology Main Business Overview
13.14.5 Wuhan Keqian Biology Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rinderpest Virus Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rinderpest Virus Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Rinderpest Virus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 6. Global Rinderpest Virus Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Rinderpest Virus Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rinderpest Virus Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Rinderpest Virus Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 10. Global Rinderpest Virus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 11. Global Rinderpest Virus Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Rinderpest Virus Vaccine Revenue by Application (2018-2023)
Table 13. Global Rinderpest Virus Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Rinderpest Virus Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 15. Global Rinderpest Virus Vaccine Sales by Company (2018-2023) & (K Doses)
Table 16. Global Rinderpest Virus Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Rinderpest Virus Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rinderpest Virus Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Rinderpest Virus Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 20. Key Manufacturers Rinderpest Virus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Rinderpest Virus Vaccine Products Offered
Table 22. Rinderpest Virus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rinderpest Virus Vaccine Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Rinderpest Virus Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rinderpest Virus Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rinderpest Virus Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rinderpest Virus Vaccine Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Rinderpest Virus Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rinderpest Virus Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rinderpest Virus Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rinderpest Virus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Rinderpest Virus Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Rinderpest Virus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rinderpest Virus Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Rinderpest Virus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Rinderpest Virus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Rinderpest Virus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Rinderpest Virus Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Rinderpest Virus Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rinderpest Virus Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Rinderpest Virus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Rinderpest Virus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Rinderpest Virus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Rinderpest Virus Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Rinderpest Virus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rinderpest Virus Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Rinderpest Virus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Rinderpest Virus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Rinderpest Virus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Rinderpest Virus Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rinderpest Virus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rinderpest Virus Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rinderpest Virus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Rinderpest Virus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Rinderpest Virus Vaccine
Table 58. Key Market Challenges & Risks of Rinderpest Virus Vaccine
Table 59. Key Industry Trends of Rinderpest Virus Vaccine
Table 60. Rinderpest Virus Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rinderpest Virus Vaccine Distributors List
Table 63. Rinderpest Virus Vaccine Customer List
Table 64. Global Rinderpest Virus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Rinderpest Virus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rinderpest Virus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Rinderpest Virus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rinderpest Virus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Rinderpest Virus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rinderpest Virus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Rinderpest Virus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rinderpest Virus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Rinderpest Virus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rinderpest Virus Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Rinderpest Virus Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rinderpest Virus Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Rinderpest Virus Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Zoetis Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 80. Zoetis Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Merck Animal Health Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Animal Health Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 85. Merck Animal Health Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 86. Merck Animal Health Main Business
Table 87. Merck Animal Health Latest Developments
Table 88. Hipra Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Hipra Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 90. Hipra Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 91. Hipra Main Business
Table 92. Hipra Latest Developments
Table 93. Boehringer-Ingelheim Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Boehringer-Ingelheim Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 95. Boehringer-Ingelheim Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 96. Boehringer-Ingelheim Main Business
Table 97. Boehringer-Ingelheim Latest Developments
Table 98. Ceva Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Ceva Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 100. Ceva Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 101. Ceva Main Business
Table 102. Ceva Latest Developments
Table 103. Creative Biolabs Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Creative Biolabs Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 105. Creative Biolabs Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 106. Creative Biolabs Main Business
Table 107. Creative Biolabs Latest Developments
Table 108. China Animal Husbandry Industry Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. China Animal Husbandry Industry Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 110. China Animal Husbandry Industry Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 111. China Animal Husbandry Industry Main Business
Table 112. China Animal Husbandry Industry Latest Developments
Table 113. Jinyu Bio-technology Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Jinyu Bio-technology Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 115. Jinyu Bio-technology Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 116. Jinyu Bio-technology Main Business
Table 117. Jinyu Bio-technology Latest Developments
Table 118. TECON Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. TECON Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 120. TECON Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 121. TECON Main Business
Table 122. TECON Latest Developments
Table 123. Shenzhen Huaweite Biotechnology Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Shenzhen Huaweite Biotechnology Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 125. Shenzhen Huaweite Biotechnology Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 126. Shenzhen Huaweite Biotechnology Main Business
Table 127. Shenzhen Huaweite Biotechnology Latest Developments
Table 128. Beijing Centrebio Biology Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Beijing Centrebio Biology Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 130. Beijing Centrebio Biology Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 131. Beijing Centrebio Biology Main Business
Table 132. Beijing Centrebio Biology Latest Developments
Table 133. Guangdong Winsun Bio Pharmaceutical Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Guangdong Winsun Bio Pharmaceutical Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 135. Guangdong Winsun Bio Pharmaceutical Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 136. Guangdong Winsun Bio Pharmaceutical Main Business
Table 137. Guangdong Winsun Bio Pharmaceutical Latest Developments
Table 138. SPAH Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. SPAH Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 140. SPAH Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 141. SPAH Main Business
Table 142. SPAH Latest Developments
Table 143. Wuhan Keqian Biology Basic Information, Rinderpest Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. Wuhan Keqian Biology Rinderpest Virus Vaccine Product Portfolios and Specifications
Table 145. Wuhan Keqian Biology Rinderpest Virus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 146. Wuhan Keqian Biology Main Business
Table 147. Wuhan Keqian Biology Latest Developments
List of Figures
Figure 1. Picture of Rinderpest Virus Vaccine
Figure 2. Rinderpest Virus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rinderpest Virus Vaccine Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Rinderpest Virus Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rinderpest Virus Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live Vaccine
Figure 10. Product Picture of Inactivated Vaccine
Figure 11. Global Rinderpest Virus Vaccine Sales Market Share by Type in 2022
Figure 12. Global Rinderpest Virus Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Rinderpest Virus Vaccine Consumed in Calf
Figure 14. Global Rinderpest Virus Vaccine Market: Calf (2018-2023) & (K Doses)
Figure 15. Rinderpest Virus Vaccine Consumed in Adult Cow
Figure 16. Global Rinderpest Virus Vaccine Market: Adult Cow (2018-2023) & (K Doses)
Figure 17. Global Rinderpest Virus Vaccine Sales Market Share by Application (2022)
Figure 18. Global Rinderpest Virus Vaccine Revenue Market Share by Application in 2022
Figure 19. Rinderpest Virus Vaccine Sales Market by Company in 2022 (K Doses)
Figure 20. Global Rinderpest Virus Vaccine Sales Market Share by Company in 2022
Figure 21. Rinderpest Virus Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Rinderpest Virus Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Rinderpest Virus Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Rinderpest Virus Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Rinderpest Virus Vaccine Sales 2018-2023 (K Doses)
Figure 26. Americas Rinderpest Virus Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Rinderpest Virus Vaccine Sales 2018-2023 (K Doses)
Figure 28. APAC Rinderpest Virus Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Rinderpest Virus Vaccine Sales 2018-2023 (K Doses)
Figure 30. Europe Rinderpest Virus Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Rinderpest Virus Vaccine Sales 2018-2023 (K Doses)
Figure 32. Middle East & Africa Rinderpest Virus Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Rinderpest Virus Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Rinderpest Virus Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Rinderpest Virus Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Rinderpest Virus Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Rinderpest Virus Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Rinderpest Virus Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Rinderpest Virus Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Rinderpest Virus Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Rinderpest Virus Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Rinderpest Virus Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Rinderpest Virus Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Rinderpest Virus Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Rinderpest Virus Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Rinderpest Virus Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Rinderpest Virus Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Rinderpest Virus Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Rinderpest Virus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Rinderpest Virus Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Rinderpest Virus Vaccine
Figure 72. Industry Chain Structure of Rinderpest Virus Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Rinderpest Virus Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Rinderpest Virus Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Rinderpest Virus Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Rinderpest Virus Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Rinderpest Virus Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Rinderpest Virus Vaccine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の牛疫ウイルスワクチン市場予測 2023年-2029年] (コード：LP23DC07463)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の牛疫ウイルスワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のペット用狂犬病ウイルスワクチン市場予測 2023年-2029年
  • 世界の経口狂犬病ワクチン市場予測 2023年-2029年
  • 世界のジカウイルスIgM検査キット市場予測 2023年-2029年
  • 世界の抗呼吸器合胞体ウイルス薬市場予測 2023年-2029年
  • 世界の呼吸器合胞体ウイルス診断検査市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆